Diagnosis of 17β-hydroxysteroid dehydrogenase deficiency

References

• Hughes IA. Disorders of sex development: a new definition and classification. Best Pract. Res. Clin. Endocrinol. Metab.22(1), 119–134 (2008).
   PubMed Web of Science ®Google Scholar
• Sax L. How common is intersex? A response to Anne Fausto-Sterling. J. Sex Res.39, 174–178 (2002).
   PubMed Web of Science ®Google Scholar
• Thyen U, Lanz K, Holterhus PM, Hiort O. Epidemiology and initial management of ambiguous genitalia at birth in Germany. Horm. Res.66(4), 195–203 (2006).
   PubMedGoogle Scholar
• Hughes IA, Houk C, Ahmed SF, Lee PA, LWPES/ESPE Consensus Group: consensus statement on management of intersex disorders. Arch. Dis. Child.91, 554–563 (2006).
   PubMed Web of Science ®Google Scholar
• Consortium on the Management of Disorders of Sex Differentiation: Clinical Guidelines for the Management of Disorders of Sex Differentiation in Childhood. ISNA, CA, USA (2005).
   Google Scholar
• Saez JM, De Peretti E, Morera AM, David M, Bertrand J. Familial male pseudohermaphroditism with gynecomastia due to a testicular 17-ketosteroid reductase defect. I. Studies in vivo. J. Clin. Endocrinol. Metab.32, 604–610 (1971).
   PubMed Web of Science ®Google Scholar
• Zubrugg RP. Inborn errors in testosterone biosynthesis with reference to 17-oxosteroid reductase deficiency. Helv. Paediatr. Acta34(Suppl.), 63–77 (1974).
   Google Scholar
• Rosler A. 17 b-hydroxysteroid dehydrogenase 3 deficiency in the Mediterranean population. Pediatr. Endocrinol. Rev.3(Suppl. 3), 455–461 (2006).
   Google Scholar
• Bertelloni S, Federico G, Hiort O. 17β-hydroxysteroid dehydrogenase 3 deficiency: genetics, clinical findings, diagnosis and molecular genetics. Ital. J. Pediatr.30, 32–38 (2004).
   Google Scholar
• Lee YS, Kirk JM, Stanhope RG et al. Phenotypic variability in 17β-hydroxysteroid dehydrogenase-3 deficiency and diagnostic pitfalls. Clin. Endocrinol. (Oxf.)67(1), 20–28 (2007).
   PubMed Web of Science ®Google Scholar
• Wu X, Lukacik P, Kavanagh KL, Oppermann U. SDR-type human hydroxysteroid dehydrogenases involved in steroid hormone activation. Mol. Cell. Endocrinol.265–266, 71–76 (2007).
   PubMed Web of Science ®Google Scholar
• Moghrabi N, Andersson S. 17β-hydroxysteroid deydrogenases: physiological role in health and disease. Trends Endocrinol. Metab.9(7), 265–270 (1998).
   PubMed Web of Science ®Google Scholar
• Geissler WM, Davis DL, Wu L et al. Male pseudohermaphroditism caused by mutations of testicular 17β-hydroxysteroid dehydrogenase 3. Nat. Genet.7, 34–39 (1994).
   PubMed Web of Science ®Google Scholar
• Andersson S, Geissler WM, Wu L et al. Molecular genetics and pathophysiology of 17β-hydroxysteroid dehydrogenase 3 deficiency. J. Clin. Endocrinol. Metab.81, 130–136 (1996).
   PubMed Web of Science ®Google Scholar
• Boehmer ALM, Brinkmann AO, Sandjuijl LA et al. 17β-hydroxysteroid dehydrogenase-3 deficiency: diagnosis, phenotypic variability, population genetics and worldwide distribution of ancient and de novo mutations. J. Clin. Endocrinol. Metab.84, 4713–4721 (1999).
   PubMed Web of Science ®Google Scholar
• Boehmer ALM, Brinkmann AO, Niermeijer MF et al. 17β-hydroxysteroid dehydrogenase-3 deficiency in the Netherlands: mutational and phenotypic spectrum, diagnostic pitfalls. Horm. Res.48(Suppl. 2), 23 (1997).
   Google Scholar
• Lukacik P, Kavanagh KL, Oppermann U. Structure and function of human 17β-hydroxysteroid dehydrogenases. Mol. Cell. Endocrinol.248(1–2), 61–71 (2006).
   PubMed Web of Science ®Google Scholar
• Mindnich R, Möller G, Adamski J. The role of 17 b-hydroxysteroid dehydrogenases. Mol. Cell. Endocrinol.218(1–2), 7–20 (2004).
   PubMed Web of Science ®Google Scholar
• Labrie F, Luu-The V, Lin SX, Simard J, Labrie C. Role of 17 b-hydroxysteroid dehydrogenases in sex steroid formation in peripheral intracrine tissues. Trends Endocrinol. Metab.11(10), 421–427 (2000).
   PubMed Web of Science ®Google Scholar
• Peltoketo H, Luu-The V, Simard J, Adamski J. 17β-hydroxysteroid dehydrogenase (HSD)/17-ketosteroid reductase (KSR) family; nomeclature and main characteristics of the 17HSD/KSR enzymes. J. Mol. Endocrinol.23, 1–11 (1999).
   PubMed Web of Science ®Google Scholar
• Hoppe U, Holterhus PM, Wünsch L et al. Tissue-specific transcription profiles of sex steroid biosynthesis enzymes and the androgen receptor. J. Mol. Med.84(8), 651–659 (2006).
   Google Scholar
• Mindnich R, Haller F, Halbach F, Moeller G, Hrabé de Angelis M, Adamski J. Androgen metabolism via 17β-hydroxysteroid dehydrogenase type 3 in mammalian and non-mammalian vertebrates: comparison of the human and the zebrafish enzyme. J. Mol. Endocrinol.35(2), 305–316 (2005).
   PubMed Web of Science ®Google Scholar
• Bertelloni S, Maggio MC, Federico G, Baroncelli G, Hiort O. 17β-hydroxysteroid dehydrogenase-3 deficiency: a rare endocrine cause of male-to-female sex reversal. Gynecol. Endocrinol.22(9), 488–494 (2006).
   PubMed Web of Science ®Google Scholar
• Parisi MA, Ramsdell LA, Burns MW et al. A Gender Assessment Team: experience with 250 patients over a period of 25 years. Genet. Med.9(6), 348–357 (2007).
   Google Scholar
• Mains LM, Vakili B, Lacassie Y, Andersson S, Lindqvist A, Rock JA. 17β-hydroxysteroid dehydrogenase 3 deficiency in a male pseudohermaphrodite. Fertil. Steril.89(1), 228 E13–E17 (2008).
   Google Scholar
• Mendonca BB, Inacio M, Arnhold IJ et al. Male pseudohermaphroditism due to 17β-hydroxysteroid dehydrogenase 3 deficiency. Diagnosis, psychological evaluation, and management. Medicine (Baltimore)79, 299–309 (2000).
   PubMedGoogle Scholar
• Balducci R, Toscano V, Wright F et al. Familial male pseudohermaphroditism with gynaecomastia due to 17β-hydroxysteroid dehydrogenase deficiency. A report of 3 cases. Clin. Endocrinol.23, 439–444 (1985).
   Google Scholar
• Faienza MF, Giordani L, Acquafredda A et al. 46,XY DSD caused by a rare mutation of the 17β-hydroxysteroid dehydrogenase type 3 gene. Ital. J. Pediatr.33, 13–16 (2007).
   Google Scholar
• Rosler A, Silverstein S, Abeliovich D. A (R80Q) mutation in 17β-hydroxysteroid dehydrogenase type 3 gene among Arabs of Israel is associated with pseudohermaphroditism in males and normal asymptomatic females. J. Clin. Endocrinol. Metab.81, 1827–1831 (1996).
   PubMed Web of Science ®Google Scholar
• Rosler A. Steroid 17β-hydroxysteroid dehydrogenase deficiency in man: an inherited form of male pseudohermaphroditism. J. Steroid Biochem. Mol. Biol.43, 989–1002 (1992).
   PubMedGoogle Scholar
• Twesten W, Holterhus P, Sippell WG et al. Clinical, endocrine, and molecular genetic findings in patients with 17β-hydroxysteroid dehydrogenase deficiency. Horm. Res.53, 26–31 (2000).
   Google Scholar
• Knorr D, Bidlingmaier F, Butenandt O, Engelhardt D. 17β-hydroxysteroid-oxydoreduktase-mangel bei pseudohermaphroditismus vom typ des Reifenstein-syndroms. Klin. Wochenschr.52, 537–543 (1974).
   Google Scholar
• Virdis R, Saenger P, Senior B, New MI. Endocrine studies in a pubertal male pseudohermaphrodite with 17-ketosteroid reductase deficiency. Acta Endocrinol.87, 212–224 (1978).
   PubMedGoogle Scholar
• Ulloa-Aguirre A, Bassol S, Poo J et al. Endocrine and biochemical studies in a 46,XY phenotypically male infant with 17-ketosteroid reductase deficiency. J. Clin. Endocrinol. Metab.60, 639–643 (1985).
   Google Scholar
• Farkas A, Rosler A. Ten years experience with masculinizing genitoplasty in male pseudohermaphroditism due to 17β-hydroxysteroid dehydrogenase deficiency. Eur. J. Pediatr.153(Suppl. 2), S88–S90 (1993).
   Google Scholar
• Cohen-Kettenis PT. Gender change in 46,XY persons with 5a-reductase-2 deficiency and 17a-hydroxysteroid dehydrogenase-3 deficiency. Arch Sex. Behav.34, 399–410 (2005).
   PubMed Web of Science ®Google Scholar
• Hiort O, Reinecke S, Thyen U et al. Puberty in disorders of somatosexual differentiation. J. Pediatr. Endocrinol. Metab.16(Suppl. 2), 297–306 (2003).
   PubMed Web of Science ®Google Scholar
• Bertelloni S, Dati E, Baroncelli GI. Disorders of sex development: hormonal management in adolescence. Gynecol. Endocrinol.24(6), 339–346 (2008).
   PubMed Web of Science ®Google Scholar
• Dumic M, Plavsic V, Fattorini I, Ille J. Absent spermatogenesis despite early bilateral orchidopexy in 17-ketoreductase deficiency. Horm. Res.22, 100–110 (1985).
   Google Scholar
• Mendonca BB, Arnhold IJ, Bloise W, Andersson S, Russell DW, Wilson JD. 17β-hydroxysteroid dehydrogenase deficiency in women. J. Clin. Endocrinol. Metab.84, 802–804 (1999).
   Google Scholar
• Faisal Ahmed S, Iqbal A, Hughes IA. The testosterone:androstenedione ratio in male undermasculinization. Clin. Endocrinol.53, 697–702 (2000).
   PubMed Web of Science ®Google Scholar
• Rey R. Anti-Müllerian hormone in disorders of sex determination and differentiation. Arq. Bras. Endocrinol. Metabol.49(1), 26–36 (2005).
   Google Scholar
• Kubini K, Zachmann M, Albers N et al. Basal inhibin B and the testosterone response to human chorionic gonadotropin correlate in prepubertal boys. J. Clin. Endocrinol. Metab.85(1), 134–138 (2000).
   PubMed Web of Science ®Google Scholar
• McKeever BM, Hawkins BK, Geissler WM et al. Amino acid substitution of arginine 80 in 17β-hydroxysteroid dehydrogenase type 3 and its effect on NADPH cofactor binding and oxidation/reduction kinetics. Biochim. Biophys. Acta1601, 29–37 (2002).
   PubMed Web of Science ®Google Scholar
• Faienza MF, Giordani L, Delvecchio M, Cavallo L. Clinical, endocrine, and molecular findings in 17β-hydroxysteroid dehydrogenase type 3 deficiency. J. Endocrinol. Invest.31(1), 85–91 (2008).
   PubMed Web of Science ®Google Scholar
• Bilbao RJ, Loridan L, Audì L, Gonzalo E, Castaño L. A novel missense (R80W) mutation in 17-β-hydroxysteroid dehydrogenase type 3 gene associated with male pseudohermaphroditism. Eur. J. Endocrinol.139, 330–333 (1998).
   PubMed Web of Science ®Google Scholar
• Can S, Zhu YS, Cai LQ et al. The identification of 5 a-reductase-2 and 17 b-hydroxysteroid dehydrogenase-3 gene defects in male pseudohermaphrodites from a Turkish kindred. J. Clin. Endocrinol. Metab.83, 560–569 (1998).
   Google Scholar
• Moghrabi N, Hughes IA, Dunaif A, Andersson S. Deleterious missense mutations and silent polymorphism in the human 17β-hydroxysteroid dehydrogenase 3 gene (HSD17β3). J. Clin. Endocrinol. Metab.83, 2855–2860 (1998).
   PubMed Web of Science ®Google Scholar
• Lindqvist A, Hughes IA, Andersson S. Substitution mutation C268Y causes 17-beta-hydroxysteroid dehydrogenase 3 deficiency. J. Clin. Endocrinol. Metab.86, 921–923 (2001).
   Google Scholar
• Michel-Calemard L, Charmandari E, Acherman J, Skordis N, Morel Y. Large rearrangements of the HSD17B3 gene: a new type of mutation responsible for 17β-HSD deficiency. Horm. Res.64(Suppl. 1), 123–124 (2005).
   Google Scholar
• Imperato-McGinley J, Peterson RE, Stoller R, Goodwin WE. Male pseudohermaphroditism secondary to 17 b-hydroxysteroid dehydrogenase deficiency: gender role change with puberty. J. Clin. Endocrinol. Metab.49(3), 391–395 (1979).
   PubMed Web of Science ®Google Scholar
• Cools M, Drop SL, Wolffenbuttel KP, Oosterhuis JW, Looijenga LH. Germ cell tumors in the intersex gonad: old paths, new directions, moving frontiers. Endocr. Rev.27(5), 468–484 (2006).
   PubMed Web of Science ®Google Scholar
• Quigley CA, De Bellis A, Marschke KB, el-Awady MK, Wilson EM, French FS. Androgen receptor defects: historical, clinical, and molecular perspectives. Endocr. Rev.16, 271–321 (1995).
   PubMed Web of Science ®Google Scholar
• Wilson JD, Griffin JE, Russell DW. Steroid 5α-reductase deficiency. Endocr. Rev.14, 577–593 (1993).
   PubMed Web of Science ®Google Scholar
• Latronico AC, Arnhold IJ. Inactivating mutations of LH and FSH receptors-from genotype to phenotype. Pediatr. Endocrinol. Rev.4(1), 28–31 (2006).
   Google Scholar
• DiNapoli L, Capel B. SRY and the standoff in sex determination. Mol. Endocrinol.22(1), 1–9 (2008).
   PubMedGoogle Scholar
• Söder O. Sexual dimorphism of gonadal development. Best Pract. Res. Clin. Endocrinol. Metab.21(3), 381–391 (2007).
   Google Scholar
• Thyen U, Hampel E, Hiort O. Disorders of sex development. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz50(12), 1569–1577 (2007).
   Google Scholar